JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


First published online February 20, 2008
J Nucl Med 2008, doi:10.2967/jnumed.107.048595
© 2008 by Society of Nuclear Medicine
This Article
Right arrow Full Text (Publish Ahead of Print[PDF])
Right arrow All Versions of this Article:
jnumed.107.048595v1
49/3/375    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Moore, A. E.B.
Right arrow Articles by Fogelman, I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Moore, A. E.B.
Right arrow Articles by Fogelman, I.


Quantitative Measurements of Bone Remodeling Using 99mTc-Methylene Diphosphonate Bone Scans and Blood Sampling

Amelia E.B. Moore 1*, Glen M. Blake 1, and Ignac Fogelman 1

1 School of Medicine, King's College London, London, United Kingdom

* To whom correspondence should be addressed. E-mail: amelia.moore{at}kcl.ac.uk.


   Abstract

Quantitative studies of bone using 99mTc-methylene diphosphonate (99mTc-MDP) have a potentially valuable role in investigating the treatment of patients with metabolic bone disease. In this study we compared 3 different methods of measuring whole-skeleton 99mTc-MDP plasma clearance (Kbone) in 12 osteoporotic postmenopausal women (mean age, 67.3 y) before participation in a clinical trial of an osteoporosis therapy. The aim was to compare the consistency and accuracy of the 3 methods before their use in evaluating the subjects' response to treatment. Methods: Subjects were injected with 600 MBq 99mTc-MDP and 3 MBq 51Cr-ethylenediaminetetraacetic acid (51Cr-EDTA) and whole-body bone scan images were acquired at 10 min, 1, 2, 3, and 4 h. Two-minute static images of the thighs were acquired immediately after the 1- to 4-h whole-body scans. Six blood samples were taken between 5 min and 4 h, and free 99mTc-MDP was measured using ultrafiltration. The glomerular filtration rate (GFR) was estimated from the 51Cr-EDTA plasma curve. The methods used to evaluate Kbone were (a) the area-under-the-curve (AUC) method, in which the GFR measurement was subtracted from the total (bone plus renal) clearance (Ktotal) measured from the free 99mTc-MDP plasma curve; (b) the modified Brenner method, in which 99mTc-MDP renal clearance estimated from the whole-body counts was subtracted from the total clearance measured from the rate of elimination of tracer from soft tissue; and (c) the Patlak plot method, which was also used to derive regional values of Kbone for the skull, spine, pelvis, arms, and legs. Results: There was good agreement between the 3 methods of measuring Kbone. (mean Kbone ± SD: AUC method, 30.3 ± 6.4 mL·min-1; Brenner method, 31.1 ± 5.8 mL·min-1; Patlak method, 35.7 ± 5.8 mL·min-1). The correlation coefficients between the methods varied from r = 0.767 (P = 0.004) to r = 0.805 (P = 0.002). Regional measurements of 99mTc-MDP clearance gave the following percentages of the whole-skeleton clearance: skull, 13.3%; spine, 16.6%; pelvis, 17.2%; arms, 11.1%; legs, 23.7%. Conclusion: The 3 methods gave consistent and accurate measurements of Kbone. The Patlak method can be used to study regional as well as total-skeleton values of Kbone.

Key Words: 99mTc-methylene diphosphonate, bone remodeling, bone plasma clearance







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 2008 by the Society of Nuclear Medicine.